ICIG Ventures

ICIG Ventures sources opportunities through the parent group's extensive network of chemical and pharmaceutical manufacturing relationships across Europe and North America. The firm benefits from deal flow generated by ICIG's ongoing corporate development activity, including contact with universities, research institutes, and other corporate venture arms in the specialty-chemicals ecosystem. Its technical due-diligence capability, underwritten by ICIG's in-house engineering team, further attracts founders seeking industry-insider investors.

ICIG Ventures focuses on early-stage and seed investments, with a mandate covering venture capital generally within chemistry, biotechnology, and sustainable materials. The firm does not disclose a standardized check size range. Its co-investment posture is collaborative — it invests alongside traditional venture capital funds and other corporate venture arms, often providing not only capital but also a route to first industrial-scale production runs through ICIG's manufacturing sites.

ICIG Ventures inherits the centralized, founder-led governance model of its parent, International Chemical Investors Group. Dr. Achim Riemann remains the central figure; investment and strategic decisions flow through the parent group's executive layer rather than a standalone partnership. The firm has not disclosed a formal succession plan for either the industrial group or its venture activities. The governance structure resembles that of other European family- and founder-controlled industrial holding companies.